Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 222

1.

Irradiation of rat brain reduces P-glycoprotein expression and function.

Bart J, Nagengast WB, Coppes RP, Wegman TD, van der Graaf WT, Groen HJ, Vaalburg W, de Vries EG, Hendrikse NH.

Br J Cancer. 2007 Aug 6;97(3):322-6. Epub 2007 Jul 3.

2.

Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma.

Schot BW, Zijlstra JM, Sluiter WJ, van Imhoff GW, Pruim J, Vaalburg W, Vellenga E.

Blood. 2007 Jan 15;109(2):486-91. Epub 2006 Sep 26.

PMID:
17003382
3.

The role of serial pre-transplantation positron emission tomography in predicting progressive disease in relapsed lymphoma.

Schot BW, Pruim J, van Imhoff GW, Sluiter WJ, Vaalburg W, Vellenga E.

Haematologica. 2006 Apr;91(4):490-5. Epub 2006 Mar 1.

4.

18F-FEAU as a radiotracer for herpes simplex virus thymidine kinase gene expression: in-vitro comparison with other PET tracers.

Buursma AR, Rutgers V, Hospers GA, Mulder NH, Vaalburg W, de Vries EF.

Nucl Med Commun. 2006 Jan;27(1):25-30.

PMID:
16340720
5.

The human norepinephrine transporter in combination with 11C-m-hydroxyephedrine as a reporter gene/reporter probe for PET of gene therapy.

Buursma AR, Beerens AM, de Vries EF, van Waarde A, Rots MG, Hospers GA, Vaalburg W, Haisma HJ.

J Nucl Med. 2005 Dec;46(12):2068-75.

6.

Positron emission tomography studies of human airways using an inhaled beta-adrenoceptor antagonist, S-11C-CGP 12388.

van Waarde A, Maas B, Doze P, Slart RH, Frijlink HW, Vaalburg W, Elsinga PH.

Chest. 2005 Oct;128(4):3020-7.

PMID:
16236982
7.

Synthesis and evaluation of dopamine D3 receptor antagonist 11C-GR218231 as PET tracer for P-glycoprotein.

de Vries EF, Kortekaas R, van Waarde A, Dijkstra D, Elsinga PH, Vaalburg W.

J Nucl Med. 2005 Aug;46(8):1384-92.

8.

Influence of p53 status on the HSV-Tk/GCV-induced bystander effect in a panel of human ovarian carcinoma cell lines.

van Dillen IJ, Mulder NH, Sluiter WJ, Meijer C, de Jong S, Loncarek J, Mesnil M, de Vries EF, Vaalburg W, Hospers GA.

Oncol Res. 2005;15(3):151-9.

PMID:
16050136
9.

P-glycoprotein activity and biological response.

Vaalburg W, Hendrikse NH, Elsinga PH, Bart J, van Waarde A.

Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):257-60. Review.

PMID:
16043202
10.

Antagonism of HSV-tk transfection and ganciclovir treatment on chemotherapeutic drug sensitivity.

Van Dillen IJ, Mulder NH, Meijer C, Dam WA, Kamstra E, De Vries L, Meersma GJ, Van der Zee AG, De Vries EF, Vaalburg W, Hospers GA.

J Chemother. 2005 Jun;17(3):289-96.

PMID:
16038523
11.

New positron emission tomography tracer [(11)C]carvedilol reveals P-glycoprotein modulation kinetics.

Bart J, Dijkers EC, Wegman TD, de Vries EG, van der Graaf WT, Groen HJ, Vaalburg W, Willemsen AT, Hendrikse NH.

Br J Pharmacol. 2005 Aug;145(8):1045-51.

12.

[18F]FHPG positron emission tomography for detection of herpes simplex virus (HSV) in experimental HSV encephalitis.

Buursma AR, de Vries EF, Garssen J, Kegler D, van Waarde A, Schirm J, Hospers GA, Mulder NH, Vaalburg W, Klein HC.

J Virol. 2005 Jun;79(12):7721-7.

13.

Positron emission tomography studies on binding of central nervous system drugs and P-glycoprotein function in the rodent brain.

Elsinga PH, Hendrikse NH, Bart J, van Waarde A, Vaalburg W.

Mol Imaging Biol. 2005 Jan-Feb;7(1):37-44. Review.

PMID:
15912274
14.

Consequences of chemoresistance for the herpes simplex virus thymidine kinase/ganciclovir-induced bystander effect in a human small cell lung cancer cell line model.

Van Dillen IJ, Mulder NH, Sluiter WJ, Meijer C, De Jong S, Loncarek J, Mesnil M, De Vries EF, Vaalburg W, Hospers GA.

Anticancer Res. 2005 Jan-Feb;25(1A):255-61.

15.

In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer.

Breeuwsma AJ, Pruim J, Jongen MM, Suurmeijer AJ, Vaalburg W, Nijman RJ, de Jong IJ.

Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):668-73. Epub 2005 Mar 12.

PMID:
15765234
16.

Blood-brain barrier dysfunction in parkinsonian midbrain in vivo.

Kortekaas R, Leenders KL, van Oostrom JC, Vaalburg W, Bart J, Willemsen AT, Hendrikse NH.

Ann Neurol. 2005 Feb;57(2):176-9.

PMID:
15668963
17.

Monitoring HSVtk suicide gene therapy: the role of [(18)F]FHPG membrane transport.

Buursma AR, van Dillen IJ, van Waarde A, Vaalburg W, Hospers GA, Mulder NH, de Vries EF.

Br J Cancer. 2004 Dec 13;91(12):2079-85.

18.

Myocardial beta-adrenoceptor downregulation in idiopathic dilated cardiomyopathy measured in vivo with PET using the new radioligand (S)-[11C]CGP12388.

de Jong RM, Willemsen AT, Slart RH, Blanksma PK, van Waarde A, Cornel JH, Vaalburg W, van Veldhuisen DJ, Elsinga PH.

Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):443-7. Epub 2004 Dec 11.

PMID:
15592928
19.

Prediction of survival and therapy outcome with 11C-tyrosine PET in patients with laryngeal carcinoma.

de Boer JR, Pruim J, Albers FW, Burlage F, Vaalburg W, van der Laan BF.

J Nucl Med. 2004 Dec;45(12):2052-7.

20.

Tumor imaging with 2 sigma-receptor ligands, 18F-FE-SA5845 and 11C-SA4503: a feasibility study.

van Waarde A, Buursma AR, Hospers GA, Kawamura K, Kobayashi T, Ishii K, Oda K, Ishiwata K, Vaalburg W, Elsinga PH.

J Nucl Med. 2004 Nov;45(11):1939-45.

21.

Is 18F-3'-fluoro-3'-deoxy-L-thymidine useful for the staging and restaging of non-small cell lung cancer?

Cobben DC, Elsinga PH, Hoekstra HJ, Suurmeijer AJ, Vaalburg W, Maas B, Jager PL, Groen HM.

J Nucl Med. 2004 Oct;45(10):1677-82.

22.

Receptor imaging in the thorax with PET.

Elsinga PH, van Waarde A, Vaalburg W.

Eur J Pharmacol. 2004 Sep 19;499(1-2):1-13. Review.

PMID:
15363946
23.

The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours.

Bart J, Hollema H, Groen HJ, de Vries EG, Hendrikse NH, Sleijfer DT, Wegman TD, Vaalburg W, van der Graaf WT.

Eur J Cancer. 2004 Sep;40(14):2064-70.

PMID:
15341980
24.

Synthesis and evaluation of a fluorine-18 labeled antisense oligonucleotide as a potential PET tracer for iNOS mRNA expression.

de Vries EF, Vroegh J, Dijkstra G, Moshage H, Elsinga PH, Jansen PL, Vaalburg W.

Nucl Med Biol. 2004 Jul;31(5):605-12.

PMID:
15219279
25.

PET for the evaluation of pleural thickening observed on CT.

Kramer H, Pieterman RM, Slebos DJ, Timens W, Vaalburg W, Ko√ęter GH, Groen HJ.

J Nucl Med. 2004 Jun;45(6):995-8.

26.

PET imaging of beta-adrenoceptors in human brain: a realistic goal or a mirage?

van Waarde A, Vaalburg W, Doze P, Bosker FJ, Elsinga PH.

Curr Pharm Des. 2004;10(13):1519-36. Review.

PMID:
15134573
27.

PET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS.

Elsinga PH, Hendrikse NH, Bart J, Vaalburg W, van Waarde A.

Curr Pharm Des. 2004;10(13):1493-503. Review.

PMID:
15134571
28.

In vivo imaging of hepatobiliary transport function mediated by multidrug resistance associated protein and P-glycoprotein.

Hendrikse NH, Kuipers F, Meijer C, Havinga R, Bijleveld CM, van der Graaf WT, Vaalburg W, de Vries EG.

Cancer Chemother Pharmacol. 2004 Aug;54(2):131-8. Epub 2004 Apr 30.

PMID:
15118837
29.

Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.

van Waarde A, Cobben DC, Suurmeijer AJ, Maas B, Vaalburg W, de Vries EF, Jager PL, Hoekstra HJ, Elsinga PH.

J Nucl Med. 2004 Apr;45(4):695-700.

30.

Detection and grading of soft tissue sarcomas of the extremities with (18)F-3'-fluoro-3'-deoxy-L-thymidine.

Cobben DC, Elsinga PH, Suurmeijer AJ, Vaalburg W, Maas B, Jager PL, Hoekstra HJ.

Clin Cancer Res. 2004 Mar 1;10(5):1685-90.

31.

18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET.

Cobben DC, van der Laan BF, Maas B, Vaalburg W, Suurmeijer AJ, Hoekstra HJ, Jager PL, Elsinga PH.

J Nucl Med. 2004 Feb;45(2):226-31.

32.

Comparison of gated PET with MRI for evaluation of left ventricular function in patients with coronary artery disease.

Slart RH, Bax JJ, de Jong RM, de Boer J, Lamb HJ, Mook PH, Willemsen AT, Vaalburg W, van Veldhuisen DJ, Jager PL.

J Nucl Med. 2004 Feb;45(2):176-82.

33.

The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis.

Bastiaannet E, Groen H, Jager PL, Cobben DC, van der Graaf WT, Vaalburg W, Hoekstra HJ.

Cancer Treat Rev. 2004 Feb;30(1):83-101. Review.

PMID:
14766127
34.

Evaluation of [18F]fluorinated sigma receptor ligands in the conscious monkey brain.

Elsinga PH, Tsukada H, Harada N, Kakiuchi T, Kawamura K, Vaalburg W, Kimura Y, Kobayashi T, Ishiwata K.

Synapse. 2004 Apr;52(1):29-37.

PMID:
14755630
35.

Quantitative assessment of P-glycoprotein function in the rat blood-brain barrier by distribution volume of [11C]verapamil measured with PET.

Bart J, Willemsen AT, Groen HJ, van der Graaf WT, Wegman TD, Vaalburg W, de Vries EG, Hendrikse NH.

Neuroimage. 2003 Nov;20(3):1775-82.

PMID:
14642487
36.

Predictive value of early 18F-fluoro-deoxyglucose positron emission tomography in chemosensitive relapsed lymphoma.

Schot B, van Imhoff G, Pruim J, Sluiter W, Vaalburg W, Vellenga E.

Br J Haematol. 2003 Oct;123(2):282-7.

PMID:
14531910
37.

Synthesis and in vivo evaluation of 18F-desbromo-DuP-697 as a PET tracer for cyclooxygenase-2 expression.

de Vries EF, van Waarde A, Buursma AR, Vaalburg W.

J Nucl Med. 2003 Oct;44(10):1700-6.

38.

Visualization of beta-Adrenoceptors Using PET.

Elsinga PH, van Waarde A, Visser TJ, Vaalburg W.

Clin Positron Imaging. 1998 Mar;1(2):81-94.

PMID:
14516596
39.

Evaluation of [18F]FHPG as PET tracer for HSVtk gene expression.

de Vries EF, van Dillen IJ, van Waarde A, Willemsen AT, Vaalburg W, Mulder NH, Hospers GA.

Nucl Med Biol. 2003 Aug;30(6):651-60.

PMID:
12900291
40.

Therapy evaluation of laryngeal carcinomas by tyrosine-pet.

De Boer JR, Pruim J, Burlage F, Krikke A, Tiebosch AT, Albers FW, Vaalburg W, Van Der Laan BF.

Head Neck. 2003 Aug;25(8):634-44.

PMID:
12884346
41.

11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer.

de Jong IJ, Pruim J, Elsinga PH, Vaalburg W, Mensink HJ.

Eur Urol. 2003 Jul;44(1):32-8; discussion 38-9.

PMID:
12814672
42.

Synthesis and evaluation of 11C- and 18F-labeled 1-[2-(4-alkoxy-3-methoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazines as sigma receptor ligands for positron emission tomography studies.

Kawamura K, Elsinga PH, Kobayashi T, Ishii S, Wang WF, Matsuno K, Vaalburg W, Ishiwata K.

Nucl Med Biol. 2003 Apr;30(3):273-84.

PMID:
12745019
43.

Evaluation of fluorine-18-labeled alkylating agents as potential synthons for the labeling of oligonucleotides.

de Vries EF, Vroegh J, Elsinga PH, Vaalburg W.

Appl Radiat Isot. 2003 Apr;58(4):469-76.

PMID:
12672626
44.

L-1-11C-tyrosine PET in patients with laryngeal carcinomas: comparison of standardized uptake value and protein synthesis rate.

de Boer JR, Pruim J, van der Laan BF, Que TH, Willemsen AT, Albers FW, Vaalburg W.

J Nucl Med. 2003 Mar;44(3):341-6.

45.

Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.

de Jong IJ, Pruim J, Elsinga PH, Vaalburg W, Mensink HJ.

J Nucl Med. 2003 Mar;44(3):331-5.

46.
47.

Endothelial dysfunction and reduced myocardial perfusion reserve in heart failure secondary to coronary artery disease.

de Jong RM, Blanksma PK, Cornel JH, Van den Heuvel AF, Siebelink HM, Vaalburg W, van Veldhuisen DJ.

Am J Cardiol. 2003 Feb 15;91(4):497-500. No abstract available.

PMID:
12586279
48.

An improved method for the preparation of [11C]verapamil.

Wegman TD, Maas B, Elsinga PH, Vaalburg W.

Appl Radiat Isot. 2002 Oct;57(4):505-7.

PMID:
12361330
49.

Visualisation of bladder cancer using (11)C-choline PET: first clinical experience.

de Jong IJ, Pruim J, Elsinga PH, Jongen MM, Mensink HJ, Vaalburg W.

Eur J Nucl Med Mol Imaging. 2002 Oct;29(10):1283-8. Epub 2002 Jul 27.

PMID:
12271408
50.

5-HT(1A) receptor imaging in the human brain: effect of tryptophan depletion and infusion on [(18)F]MPPF binding.

Udo de Haes JI, Bosker FJ, Van Waarde A, Pruim J, Willemsen AT, Vaalburg W, Den Boer JA.

Synapse. 2002 Nov;46(2):108-15.

PMID:
12211089

Supplemental Content

Loading ...
Support Center